
Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. (AURX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AURX · as of Jun 9, 2026
Key Statistics
Explore Nuo Therapeutics, Inc. Data
aurx stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
aurx competitorsStock Performance
Full HistoryAbout Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineere…
what is nuo therapeutics, inc. · aurx stock overview · nuo therapeutics, inc. company profile · who is nuo therapeutics, inc. ceo · aurx OTC · nuo therapeutics, inc. headquarters · nuo therapeutics, inc. business segments
About Stock Overview & Key Data
Nuo Therapeutics, Inc. (AURX) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 24, 2017. As of the latest trading session, AURX stock price is $1.00, with a market capitalization of $48.4M. The stock has returned -36.71% over the past 12 months and -49.24% year-to-date.
In fiscal year 2025, Nuo Therapeutics, Inc. reported revenue of $3.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nuo Therapeutics, Inc. (AURX) stock price is $1.00. The stock is traded on OTC under the ticker symbol AURX. The 52-week range is $0.84 – $3.23.